<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02650934</url>
  </required_header>
  <id_info>
    <org_study_id>114S309</org_study_id>
    <nct_id>NCT02650934</nct_id>
  </id_info>
  <brief_title>Predictors of Heart Failure After ST-segment Elevation Myocardial Infarction (HF-EXPRESS)</brief_title>
  <acronym>HF-EXPRESS</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Dr. Nafiz Korez Sincan State Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ankara Diskapi Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ankara Numune Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ankara Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dr. Nafiz Korez Sincan State Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: The purpose of this project is to study the post miyocardial infaction (MI) damage
      and subsequently developed post-infarct cardiac repair process on the basis of cellular,
      molecular and imaging techniques. Besides this, whole genomesequencing and analysis (GWAS)
      will be performed to determine common varying genetic loci in order to anticipate
      whetherthese findings and its related pathways would be the predictors of adverse remodeling
      after MI or not.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A brief description of the issue and the original value of the subject: Epidemiological
      studies show a clear increase ininfarct-related complications due to increased survival after
      MI and aging population. Heart failure is the most prevalent complication after MI, which has
      reached epidemic proportions in western societies. For the period between 2010 and
      2030,according to projections made in developed countries, about 10% increment in all
      cardiovascular disease is being predictedhowever increment in heart failure (HF) would be
      such a dramatic figure which is about 25%. HF is an increasing burden tosociety and
      healthcare systems, since its prevalence and incidence is dramatically increasing. There has
      not been aprospective study that assesses the exact cellular and geometric course after MI in
      human. This study will allow us tounderstand the behavior of cells involved in cardiac repair
      after MI. In addition, it will show us the exact functional andgeometric course after MI.
      Finally, the current study will also provide novel diagnostic and therapeutic targets via
      genomic andproteomic studies. All together, we envision to find new efficient ways to
      identify/treat patients at risk to develop HF after MI.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2019</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Cardiovascular death, nonfatal MI, stroke</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">312</enrollment>
  <condition>Heart Failure and ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Adverse remodelling</arm_group_label>
    <description>EF below 40% following MI and remain below 40% after reperfusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>not adverse remodelling</arm_group_label>
    <description>EF below 40% following MI and remodelling after reperfusion or EF above 40 % following MI</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutanous coronary intervention</intervention_name>
    <arm_group_label>Adverse remodelling</arm_group_label>
    <arm_group_label>not adverse remodelling</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral Blood specimen
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        18-80 years old patients with myocardial infarction in the first 12 hours
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        18-80 years old patients with myocardial infarction in the first 12 hours TIMI 3 flow
        following PCI

        Exclusion Criteria:

        Right ventiricular myocardial infarction Cardiogenic shock History of CABG, PCI or valvular
        disease History of Cardiomyopathy severe LV hypertrophy No reflow after PCI Chronic kidney
        disease (GFR&lt;60) Systemic inflammatory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Omer Sahin, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Dr.Nafiz Korez state hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ferhat Eyyupkoca, MD</last_name>
    <phone>+905056864352</phone>
    <email>ferhateyupkoca@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ahmet G Ertem, MD</last_name>
    <phone>+905323944334</phone>
    <email>agertem@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dr.Nafiz Korez state hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06810</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ferhat Eyyupkoca, MD</last_name>
      <phone>+905056864352</phone>
      <email>ferhateyupkoca@hotmail.com</email>
    </contact>
    <contact_backup>
      <phone>+905325221520</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <results_reference>
    <citation>Ørn S, Ueland T, Manhenke C, Sandanger Ø, Godang K, Yndestad A, Mollnes TE, Dickstein K, Aukrust P. Increased interleukin-1β levels are associated with left ventricular hypertrophy and remodelling following acute ST segment elevation myocardial infarction treated by primary percutaneous coronary intervention. J Intern Med. 2012 Sep;272(3):267-76. doi: 10.1111/j.1365-2796.2012.02517.x. Epub 2012 Feb 26.</citation>
    <PMID>22243053</PMID>
  </results_reference>
  <results_reference>
    <citation>Palazzuoli A, Beltrami M, Gennari L, Dastidar AG, Nuti R, McAlindon E, Angelini GD, Bucciarelli-Ducci C. The impact of infarct size on regional and global left ventricular systolic function: a cardiac magnetic resonance imaging study. Int J Cardiovasc Imaging. 2015 Jun;31(5):1037-44. doi: 10.1007/s10554-015-0657-3. Epub 2015 Apr 12.</citation>
    <PMID>25863669</PMID>
  </results_reference>
  <results_reference>
    <citation>Scott AE, Semple SI, Redpath TW, Hillis GS. Low-dose dobutamine adds incremental value to late gadolinium enhancement cardiac magnetic resonance in the prediction of adverse remodelling following acute myocardial infarction. Eur Heart J Cardiovasc Imaging. 2013 Sep;14(9):906-13. doi: 10.1093/ehjci/jes320. Epub 2013 Jan 12.</citation>
    <PMID>23313958</PMID>
  </results_reference>
  <verification_date>June 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 7, 2016</study_first_submitted>
  <study_first_submitted_qc>January 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 8, 2016</study_first_posted>
  <last_update_submitted>January 7, 2016</last_update_submitted>
  <last_update_submitted_qc>January 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STEMI, Heart Failure, Inflammation, Haptoglobin Polymorphisms, Adverse Remodeling, Genetics, GWAS, MRI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

